Bowil Biotech sp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-11-16
Share capital
2,400,000.00 PLN
Registered address
Skandynawska 7, 84-120 Władysławowo, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 88 days for 2021).

  • 2025not filed
  • 202408/07/2025
  • 202316/07/2024
  • 202203/07/2023
  • 202111/10/2022
  • 202028/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Other manufacturing104 / 493
Top 21%
Sector · Manufacturing3,240 / 11,963
Top 27%
Voivodeship · Pomorskie5,238 / 32,702
Top 16%
Country · Poland82,383 / 496,474
Top 17%

Results vs industry

Revenue
This companyUSD 1.98mMedianUSD 287.80kAverageUSD 4.92m
Net profit
This companyUSD 428.18kMedianUSD 10.65kAverageUSD 206.72k
Operating costs
This companyUSD 1.45mMedianUSD 269.05kAverageUSD 4.50m
Assets
This companyUSD 3.65mMedianUSD 221.07kAverageUSD 5.78m

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2012.

MarkNumberClassesStatusProtected until
BOWIL (word)Z.4028061, 3, 5, 10, 35, 42Protected Jul 11, 2032
BOWIL BIOTECH (word)Z.4028081, 3, 5, 10, 35, 42Expired –
celmat (word)Z.4025171, 3, 5, 10, 35Expired –
MarkProtected until
BOWIL (word)Jul 11, 2032
BOWIL BIOTECH (word)–
celmat (word)–

Authorized Representatives

Norbert Wilandt – President of the Management Board & Management Board Member

Manner of representation

To make declarations of will and sign on behalf of the company, each member of the management board is authorized to act independently, regardless of the function held.

Ownership

OwnerSharesShare valueStake
4,800$648,298.22100%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2007-09-27 to 2026-01-14.

Reason for removal: Art. 96 ust. 6-8

Debt

No entries in the National Debtors Register (KRZ).

Public aid

13 public aid cases recorded, with a total value of $350,238.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$3,964
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,961
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,936

European Funds

ProjectEU co-financing
Increasing the competitiveness and reach of Bowil Biotech by entering new international sales markets through an investment to launch production of a new biomaterial for manufacturing implants, resulting from the company's own research and development work
$247.7K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Biovico sp. z o.o.
Fabryka Aparatury Elektromedycznej Famed Łódź S.A.
Bifarm sp. z o.o.
Esvico sp. z o.o.
Metzer Medizin- Und Industrietechnik sp. z o.o.
Profildent sp. z o.o.
Jacek Bartosik sp. k.
Optyk Plus sp. z o.o.
Implai sp. z o.o.
Pressdots Technology sp. z o.o.

Change history

DateEvent
2016-04-07PKD change
2011-10-20PKD change
2010-09-29Switch to PKD 2007
2008-08-14Share capital increase
2008-08-14PKD change

FAQ

Last updated: 2026-02-17